Alison Pilgrim

1.8k total citations · 1 hit paper
21 papers, 1.4k citations indexed

About

Alison Pilgrim is a scholar working on Psychiatry and Mental health, Surgery and Physiology. According to data from OpenAlex, Alison Pilgrim has authored 21 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 8 papers in Surgery and 7 papers in Physiology. Recurrent topics in Alison Pilgrim's work include Migraine and Headache Studies (13 papers), Sympathectomy and Hyperhidrosis Treatments (7 papers) and Trigeminal Neuralgia and Treatments (6 papers). Alison Pilgrim is often cited by papers focused on Migraine and Headache Studies (13 papers), Sympathectomy and Hyperhidrosis Treatments (7 papers) and Trigeminal Neuralgia and Treatments (6 papers). Alison Pilgrim collaborates with scholars based in United States, Netherlands and Germany. Alison Pilgrim's co-authors include Elizabeth Ashford, Michel D. Ferrari, Uwe Reuter, Martti Färkkilâ, Michael Gent, Jean-Pierre Boissel, L A Harker, Laura E. Niklason, Jeffrey H. Lawson and Stanisław Przywara and has published in prestigious journals such as The Lancet, Neurology and The Lancet Neurology.

In The Last Decade

Alison Pilgrim

21 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials

2016 260 citations Jeffrey H. Lawson, Marc H. Glickman et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alison Pilgrim United States	16	807	588	494	456	260	21	1.4k
Noah Rosen United States	15	493 0.6×	299 0.5×	205 0.4×	119 0.3×	14 0.1×	48	824
Manning J. Sabatier United States	20	59 0.1×	207 0.4×	212 0.4×	253 0.6×	34 0.1×	36	1.2k
A Chantraine Switzerland	20	370 0.5×	259 0.4×	98 0.2×	540 1.2×	11 0.0×	63	1.6k
Sadayuki Ito Japan	19	101 0.1×	389 0.7×	372 0.8×	679 1.5×	21 0.1×	120	1.2k
Ellen Merete Hagen Norway	20	179 0.2×	1.0k 1.7×	147 0.3×	461 1.0×	8 0.0×	43	1.5k
Richard L. Boortz-Marx United States	18	158 0.2×	73 0.1×	239 0.5×	543 1.2×	7 0.0×	20	1.4k
Günşah Şahin Türkiye	20	222 0.3×	76 0.1×	182 0.4×	183 0.4×	5 0.0×	50	1.1k
Masayoshi Morozumi Japan	21	93 0.1×	375 0.6×	311 0.6×	724 1.6×	27 0.1×	94	1.3k
Menno E. Sluijter Switzerland	23	200 0.2×	777 1.3×	552 1.1×	578 1.3×	3 0.0×	35	1.7k
Kyoung Hyo Choi South Korea	21	115 0.1×	373 0.6×	288 0.6×	446 1.0×	15 0.1×	66	1.3k

Countries citing papers authored by Alison Pilgrim

Since Specialization

Citations

This map shows the geographic impact of Alison Pilgrim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Pilgrim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Pilgrim more than expected).

Fields of papers citing papers by Alison Pilgrim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Pilgrim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Pilgrim. The network helps show where Alison Pilgrim may publish in the future.

Co-authorship network of co-authors of Alison Pilgrim

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Pilgrim. A scholar is included among the top collaborators of Alison Pilgrim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Pilgrim. Alison Pilgrim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jakimowicz, Tomasz, Stanisław Przywara, Alison Pilgrim, et al.. (2022). Five Year Outcomes in Patients with End Stage Renal Disease Who Received a Bioengineered Human Acellular Vessel for Dialysis Access. EJVES Vascular Forum. 54. 58–63. 22 indexed citations

Gutowski, Piotr, Shawn M. Gage, Marek Iłżecki, et al.. (2020). Arterial reconstruction with human bioengineered acellular blood vessels in patients with peripheral arterial disease. Journal of Vascular Surgery. 72(4). 1247–1258. 76 indexed citations

Halbert, Ronald J., et al.. (2020). Patency of ePTFE Arteriovenous Graft Placements in Hemodialysis Patients: Systematic Literature Review and Meta-Analysis. Kidney360. 1(12). 1437–1446. 22 indexed citations

Lawson, Jeffrey H., Marc H. Glickman, Marek Iłżecki, et al.. (2016). Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials. The Lancet. 387(10032). 2026–2034. 260 indexed citations breakdown →

Lawson, Jeffrey H., Shannon L. M. Dahl, Heather L. Prichard, et al.. (2014). VS5 Human Tissue-Engineered Grafts for Hemodialysis: Development, Preclinical Data, and Early Investigational Human Implant Experience. Journal of Vascular Surgery. 59(6). 32S–33S. 8 indexed citations

Färkkilâ, Martti, Hans‐Christoph Diener, Gilles Géraud, et al.. (2012). Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study. The Lancet Neurology. 11(5). 405–413. 138 indexed citations

Färkkilâ, Martti, Hans‐Christoph Diener, Gilles Géraud, et al.. (2012). Iconographies supplémentaires de l'article : Efficacy and tolerability of lasmiditan, an oral 5-HT 1F receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study. 6 indexed citations

Ferrari, Michel D., Martti Färkkilâ, Uwe Reuter, et al.. (2010). Acute treatment of migraine with the selective 5-HT_1F receptor agonist lasmiditan – A randomised proof-of-concept trial. Cephalalgia. 30(10). 1170–1178. 124 indexed citations

Harker, L A, Jean-Pierre Boissel, Alison Pilgrim, & Michael Gent. (1999). Comparative Safety and Tolerability of Clopidogrel and Aspirin. Drug Safety. 21(4). 325–335. 117 indexed citations

10.

Touchon, J., L. Bertin, Alison Pilgrim, Elizabeth Ashford, & A. Bès. (1996). A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine. Neurology. 47(2). 361–365. 48 indexed citations

11.

Monstad, I., et al.. (1995). Preemptive Oral Treatment With Sumatriptan During a Cluster Period. Headache The Journal of Head and Face Pain. 35(10). 607–613. 69 indexed citations

12.

Pilgrim, Alison. (1994). The Clinical Profile of Sumatriptan: Efficacy in Migraine. European Neurology. 34(2). 26–34. 13 indexed citations

13.

Ferrari, Michel D., et al.. (1994). Oral Sumatriptan: Effect of a Second Dose, and Incidence and Treatment of Headache Recurrences. Cephalalgia. 14(5). 330–338. 87 indexed citations

14.

Bates, D., Elizabeth Ashford, Rachel Dawson, et al.. (1994). Subcutaneous sumatriptan during the migraine aura. Neurology. 44(9). 1587–1587. 150 indexed citations

15.

Tansey, Michael, et al.. (1993). Long-Term Experience with Sumatriptan in the Treatment of Migraine. European Neurology. 33(4). 310–315. 32 indexed citations

16.

Ekbom, Karl, Elisabet Waldenlind, J. Alexander Cole, Alison Pilgrim, & Andrew J. T. Kirkham. (1992). Sumatriptan in Chronic Cluster Headache: Results of Continuous Treatment for Eleven Months. Cephalalgia. 12(4). 254–256. 37 indexed citations

17.

Pilgrim, Alison, et al.. (1992). Cardiorespiratory distress after sumatriptan given by injection. BMJ. 305(6855). 714–714. 5 indexed citations

18.

Visser, W. Hester, et al.. (1992). Treatment of Migraine Attacks with Subcutaneous Sumatriptan: First Placebo-Controlled Study. Cephalalgia. 12(5). 308–313. 31 indexed citations

19.

Pilgrim, Alison. (1991). Methodology of Clinical Trials of Sumatriptan in Migraine and Cluster Headache. European Neurology. 31(5). 295–299. 91 indexed citations

20.

Ferrari, Michel D., et al.. (1989). Subcutaneous GR43175 in the Treatment of Acute Migraine: An International Study. Cephalalgia. 9(10_suppl). 348–348. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact